We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$235M
AUM Growth
+$45.8M
Cap. Flow
+$2.22M
Cap. Flow %
0.95%
Top 10 Hldgs %
86.19%
Holding
18
New
3
Increased
5
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$23.2M
2
SNY icon
Sanofi
SNY
+$8.45M
3
BIIB icon
Biogen
BIIB
+$1.35M
4
EXEL icon
Exelixis
EXEL
+$1M
5
EOLS icon
Evolus
EOLS
+$780K

Top Sells

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$13.3M
2
CAH icon
Cardinal Health
CAH
+$9.27M
3
JNJ icon
Johnson & Johnson
JNJ
+$6.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.39M
5
UTHR icon
United Therapeutics
UTHR
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$25.8B
$40.9M 17.44%
97,646
-3,500
-3% -$1.18M
ENTA icon
2
Enanta Pharmaceuticals
ENTA
$366M
$25.3M 10.78%
2,114,444
– –
JAZZ icon
3
Jazz Pharmaceuticals
JAZZ
$15.9B
$22.1M 9.42%
167,816
+3,000
+2% +$360K
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.6B
$22M 9.36%
+405,450
New +$23.2M
EXEL icon
5
Exelixis
EXEL
$13.3B
$21.4M 9.12%
518,526
+25,000
+5% +$1M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.59B
$17.4M 7.4%
363,479
-108,897
-23% -$4.39M
SNY icon
7
Sanofi
SNY
$103B
$15.3M 6.51%
323,946
+175,000
+117% +$8.45M
AVDL
8
DELISTED
Avadel Pharmaceuticals
AVDL
$14.6M 6.22%
955,860
-3,017
-0.3% -$39.3K
GSK icon
9
GSK
GSK
$104B
$11.7M 5%
271,729
– –
CAH icon
10
Cardinal Health
CAH
$53.9B
$11.6M 4.93%
73,745
-60,000
-45% -$9.27M
INDV icon
11
Indivior Pharmaceuticals
INDV
$4.73B
$8.19M 3.49%
339,532
-634,942
-65% -$13.3M
BNTX icon
12
BioNTech
BNTX
$22.9B
$7.83M 3.33%
79,366
+5,984
+8% +$640K
ALKS icon
13
Alkermes
ALKS
$8.22B
$6.24M 2.66%
207,822
– –
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$307M
$5.89M 2.51%
1,180,388
+155,505
+15% +$720K
REGN icon
15
Regeneron Pharmaceuticals
REGN
$78.5B
$2.25M 0.96%
4,000
– –
BIIB icon
16
Biogen
BIIB
$30B
$1.4M 0.6%
+10,000
New +$1.35M
EOLS icon
17
Evolus
EOLS
$385M
$614K 0.26%
+100,000
New +$780K
JNJ icon
18
Johnson & Johnson
JNJ
$618B
– –
-40,000
Closed -$6.11M

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Krensavage Asset Management held 18 positions worth $235M, up 24% from $189M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Krensavage Asset Management's Q3 2025 filing shows 3 new, 5 increased, 5 reduced and 1 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 405,450 shares worth $22M. The largest sale was Indivior Pharmaceuticals, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Krensavage Asset Management's largest Q3 2025 buy was BioMarin Pharmaceuticals: 405,450 shares worth $22M.
  • Krensavage Asset Management added most to Sanofi in Q3 2025, an estimated $8.45M increase.
  • Krensavage Asset Management's biggest Q3 2025 reduction was Indivior Pharmaceuticals, cutting an estimated $13.3M.
  • Krensavage Asset Management fully exited Johnson & Johnson in Q3 2025, selling an estimated $6.11M.
  • Krensavage Asset Management's ten largest holdings make up 86% of its $235M portfolio in Q3 2025.
  • Krensavage Asset Management opened 3 new positions and closed 1 in Q3 2025.
  • Krensavage Asset Management's portfolio value rose 24% quarter-over-quarter to $235M.

Based on Krensavage Asset Management's 13F filing for Q3 2025, filed 17 Nov 2025.